<DOC>
	<DOC>NCT01353820</DOC>
	<brief_summary>The objective of this study is to investigate the effect of Lactobacillus Delbruckii lactis (DN111244) fermented milk consumption on relative change of plasma LDL-cholesterol concentration in hypercholesterolaemic adults after 8 weeks of product consumption versus control product.</brief_summary>
	<brief_title>Effects of Lactobacillus Delbruckii Lactis DN111244 Fermented Milk Consumption on Plasma Lipids Levels in Hypercholesterolaemic Adults</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>male and female aged 1875 years; BMI between 19 and 30 kg/m2, LDLcholesterol plasma level between 130 mg/dL to 190 mg/dL (bounds included) with or without statin monotherapy, stabilized hypercholesterolemia (since more than 3 months), accepting to follow the dietary recommendations advisable for hypercholesterolemic patient (NCEPATP III guidelines), used to consume dairy products, for female: effective contraceptive methods used, agreeing to a written informed consent plasma triglycerides (TG) levels &gt; 350 mg/dL (4 mmol//L), any cardiovascular event (infarction, angina, surgical or endocoronary intervention, stroke, peripheral arteriosclerosis, etc) in the last 6 months, known allergy or hypersensitivity to milk proteins, systemic treatment or topical treatment likely to interfere with evaluation of the study parameters, subject currently involved in a clinical trial or in an exclusion period following participation in another clinical tria, subject in a situation which in the investigator's opinion could interfere with optimal participation in the present study or could constitute a special risk for the subject, diabetic subjects (type I and type II), any kind of disease likely to interfere with the evaluation of efficiency or safety of the product, for female subject: pregnancy, breast feeding or intention to become pregnant during the study, for female subject: subject likely to change her contraceptive method during the study, active heavy cigarette smokers (reported more than 20 cigarettes / day), subjects who are actively participating in a weight loss program or have participated in a weight loss program in the three months prior to screening for the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Midly hypercholesterolemic subjects</keyword>
	<keyword>Probiotic</keyword>
	<keyword>Cholesterol lowering</keyword>
	<keyword>Dairy</keyword>
</DOC>